-1.18070724367814E-06 0.000177106086545848 -2.95176810911144E-05 5.90353621818933E-05 0.00064938898400133 -8.85530432730077E-05 0.000206623767636794 0.000383729854182642
Sign Up Today X
Thanks for submitting the form.
Stockreport

OpenAI's GPT-Rosalind heats up AI competition in life sciences [Yahoo! Finance]

Alphabet Inc. - Class C Capital Stock (GOOG)  More Company Research Source: Yahoo! Finance
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
VCs have poured millions of dollars into AI life sciences startups under the assumption that their applications—like drug discovery—require bespoke, proprietary data and specialized model architectures that frontier labs wouldn't bother to build. Although investors agree that this assumption is now out the window, they see the news as a positive. “The message is clear: Life sciences have moved from being a side interest to a top priority for leading AI labs,” said Simon Turner, a partner in Sofinnova Partners ' digital medicine strategy. “[GPT-Rosalind] will likely accelerate competition.” Sign up for The Daily Pitch newsletter Subscribe Most of the large foundational model providers have, up until recently, opted to focus on ubiquitous models over specialized ones, with a few notable exceptions. Google DeepMind ‘s AlphaFold model, a leader in machine learning for drug discovery, has made massive strides in 3D protein prediction over the past few years. “DeepMind remains the [Read more]
IMPACT SNAPSHOT EVENT TIME: GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GOOG alerts
from News Quantified
GOOG
NEWS
GOOG
Earnings
GOOG
Analyst Actions
GOOG
SEC Filings
Stockreport

OpenAI's GPT-Rosalind heats up AI competition in life sciences [Yahoo! Finance]

Alphabet Inc. - Class C Capital Stock  (GOOG) 
More Company Research Source: Yahoo! Finance
Last alphabet inc. - class c capital stock earnings: 4/28 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: abc.xyz/investor
VCs have poured millions of dollars into AI life sciences startups under the assumption that their applications—like drug discovery—require bespoke, proprietary data and specialized model architectures that frontier labs wouldn't bother to build. Although investors agree that this assumption is now out the window, they see the news as a positive. “The message is clear: Life sciences have moved from being a side interest to a top priority for leading AI labs,” said Simon Turner, a partner in Sofinnova Partners ' digital medicine strategy. “[GPT-Rosalind] will likely accelerate competition.” Sign up for The Daily Pitch newsletter Subscribe Most of the large foundational model providers have, up until recently, opted to focus on ubiquitous models over specialized ones, with a few notable exceptions. Google DeepMind ‘s AlphaFold model, a leader in machine learning for drug discovery, has made massive strides in 3D protein prediction over the past few years. “DeepMind remains the [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GOOG
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS